Analyst firms · H.C. Wainwright · ICPT

H.C. Wainwright ICPT price target and rating history

Intercept Pharmaceuticals Inc. (ICPT) · Health Care

H.C. Wainwright rates Intercept Pharmaceuticals Inc. (ICPT) Buy with a $19 price target, as of its latest action on Jul 13, 2023. It has published 3 rating actions on ICPT since August 2021, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$19
Median target, all firms
Too few
Actions on ICPT
3

H.C. Wainwright price target on ICPT

$19$14$820222023202420252026
H.C. Wainwright price target on ICPT, each point a stated target, August 2021 to July 2023.

Every H.C. Wainwright rating on ICPT

Questions about H.C. Wainwright and ICPT

What is H.C. Wainwright's price target for ICPT?
H.C. Wainwright's latest stated price target for Intercept Pharmaceuticals Inc. (ICPT) is $19, from its action on Jul 13, 2023.
What is H.C. Wainwright's rating on ICPT?
H.C. Wainwright rates ICPT Buy, a bullish rating, as of Jul 13, 2023.
When did H.C. Wainwright last change its view on ICPT?
On Jul 13, 2023, H.C. Wainwright upgrades to Buy from Sell, price target $8 to $19.

All H.C. Wainwright ratingsICPT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.